Ligand Pharmaceuticals
LGND
LGND
165 hedge funds and large institutions have $1.09B invested in Ligand Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 61 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% more capital invested
Capital invested by funds: $712M → $1.09B (+$377M)
25% more funds holding
Funds holding: 132 → 165 (+33)
Holders
165
Holding in Top 10
8
Calls
$25.8M
Puts
$4.41M
Top Buyers
| 1 | +$51.5M | |
| 2 | +$38.1M | |
| 3 | +$31.2M | |
| 4 |
CCMLC
Cardinal Capital Management LLC (Connecticut)
Greenwich,
Connecticut
|
+$30.5M |
| 5 |
CM
Castleark Management
Chicago,
Illinois
|
+$11.2M |
Top Sellers
| 1 | -$27.7M | |
| 2 | -$15.6M | |
| 3 | -$15.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$7M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$6.45M |